Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDYNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.18.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.4.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KS.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.16.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LW.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LP.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.3.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
ML.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
MM.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.7.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2.3.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-18248.7Germany
LB.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.2.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.1.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.2.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
MA.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.3.1.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LB.1.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5.81NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CH.1.1.20NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBL.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.2.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
MB.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LE.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LF.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
MD.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LP.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JN.1.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
DL.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.1.15NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.529 (Omicron)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BF.41.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EG.5.1.16NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
LE.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used